Literature DB >> 19549627

The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals.

Szabolcs Kéri1, Imola Seres, Oguz Kelemen, György Benedek.   

Abstract

BACKGROUND: Previous studies reported an association between weak habituation of skin conductance orienting response and psychosis proneness. The aim of this study was to investigate the relationship among neuregulin 1 (NRG1)-stimulated AKT phosphorylation (a putative marker of psychosis), orienting response habituation, delusional ideas, anxiety, and depression in nonclinical individuals.
METHODS: One hundred twenty individuals participated in the skin conductance measurements. Weak and strong habituators were compared on measures of NRG1-stimulated AKT phosphorylation in B lymphoblasts, delusional ideas, anxiety, and depression. The predictors of delusional ideas were determined by multiple regression analysis.
RESULTS: Weak habituators displayed higher levels of delusional ideas/anxiety and a lower ratio of phosphorylated AKT as compared with strong habituators. There were 3 significant predictors of delusional ideas: decreased habituation, NRG1-induced AKT phosphorylation, and anxiety. Age, gender, education, IQ, and depression did not predict delusional ideas.
CONCLUSIONS: These results suggest that decreased habituation of arousal, NRG1-induced AKT phosphorylation, and anxiety are related to delusional ideation in the general population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549627      PMCID: PMC3004188          DOI: 10.1093/schbul/sbp063

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  37 in total

1.  Persecutory delusions: developing the understanding of belief maintenance and emotional distress.

Authors:  D Freeman; P A Garety; E Kuipers
Journal:  Psychol Med       Date:  2001-10       Impact factor: 7.723

2.  Effects of a neuregulin 1 variant on conversion to schizophrenia and schizophreniform disorder in people at high risk for psychosis.

Authors:  S Kéri; I Kiss; O Kelemen
Journal:  Mol Psychiatry       Date:  2009-02       Impact factor: 15.992

3.  Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components.

Authors:  Ying-Jiun J Chen; Madeleine A Johnson; Michael D Lieberman; Rose E Goodchild; Scott Schobel; Nicole Lewandowski; Gorazd Rosoklija; Ruei-Che Liu; Jay A Gingrich; Scott Small; Holly Moore; Andrew J Dwork; David A Talmage; Lorna W Role
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

Review 4.  Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.

Authors:  Andrea Schmitt; Eleni Parlapani; Oliver Gruber; Thomas Wobrock; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

5.  Neuregulin 1 and susceptibility to schizophrenia.

Authors:  Hreinn Stefansson; Engilbert Sigurdsson; Valgerdur Steinthorsdottir; Soley Bjornsdottir; Thordur Sigmundsson; Shyamali Ghosh; Jon Brynjolfsson; Steinunn Gunnarsdottir; Omar Ivarsson; Thomas T Chou; Omar Hjaltason; Birgitta Birgisdottir; Helgi Jonsson; Vala G Gudnadottir; Elsa Gudmundsdottir; Asgeir Bjornsson; Brynjolfur Ingvarsson; Andres Ingason; Sigmundur Sigfusson; Hronn Hardardottir; Richard P Harvey; Donna Lai; Mingdong Zhou; Daniela Brunner; Vincent Mutel; Acuna Gonzalo; Greg Lemke; Jesus Sainz; Gardar Johannesson; Thorkell Andresson; Daniel Gudbjartsson; Andrei Manolescu; Michael L Frigge; Mark E Gurney; Augustine Kong; Jeffrey R Gulcher; Hannes Petursson; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

6.  Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.

Authors:  Hao-Yang Tan; Kristin K Nicodemus; Qiang Chen; Zhen Li; Jennifer K Brooke; Robyn Honea; Bhaskar S Kolachana; Richard E Straub; Andreas Meyer-Lindenberg; Yoshitasu Sei; Venkata S Mattay; Joseph H Callicott; Daniel R Weinberger
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes.

Authors:  John M Hettema; Seon-Sook An; Jozsef Bukszar; Edwin J C G van den Oord; Michael C Neale; Kenneth S Kendler; Xiangning Chen
Journal:  Biol Psychiatry       Date:  2008-04-23       Impact factor: 13.382

Review 8.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

9.  Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.

Authors:  Effat S Emamian; Diana Hall; Morris J Birnbaum; Maria Karayiorgou; Joseph A Gogos
Journal:  Nat Genet       Date:  2004-01-25       Impact factor: 38.330

10.  A PI3-kinase-mediated negative feedback regulates neuronal excitability.

Authors:  Eric Howlett; Curtis Chun-Jen Lin; William Lavery; Michael Stern
Journal:  PLoS Genet       Date:  2008-11-28       Impact factor: 5.917

View more
  8 in total

1.  Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications.

Authors:  Tamás Kovács; Boglárka Bánsági; Oguz Kelemen; Szabolcs Kéri
Journal:  J Mol Neurosci       Date:  2014-02-23       Impact factor: 3.444

2.  CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4.

Authors:  O M Ogundele; C C Lee
Journal:  Brain Res Bull       Date:  2017-11-11       Impact factor: 4.077

Review 3.  A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.

Authors:  Jean-Martin Beaulieu
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

4.  Deletion of Rictor in catecholaminergic neurons alters locomotor activity and ingestive behavior.

Authors:  Sophia Kaska; Rebecca Brunk; Vedrana Bali; Megan Kechner; Michelle S Mazei-Robison
Journal:  Neuropharmacology       Date:  2017-02-03       Impact factor: 5.250

5.  Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice.

Authors:  Michael A Siuta; Sabrina D Robertson; Heidi Kocalis; Christine Saunders; Paul J Gresch; Vivek Khatri; Chiyo Shiota; J Philip Kennedy; Craig W Lindsley; Lynette C Daws; Daniel B Polley; Jeremy Veenstra-Vanderweele; Gregg D Stanwood; Mark A Magnuson; Kevin D Niswender; Aurelio Galli
Journal:  PLoS Biol       Date:  2010-06-08       Impact factor: 8.029

6.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

7.  Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia.

Authors:  Ching-Hsun Huang; Ju-Chun Pei; Da-Zhong Luo; Ching Chen; Yi-Wen Chen; Wen-Sung Lai
Journal:  Front Behav Neurosci       Date:  2015-01-29       Impact factor: 3.558

8.  Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia.

Authors:  Szabolcs Kéri; Csilla Szabó; Oguz Kelemen
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.